Market News
Smart Trading. Simplified.
Is this Killer new EXTRA INCOME strategy the Best Side Hustle EVER?
Have you seen this new extra-income hack yet?
Everyday Americans have been making 100%, 200%, 500%, or more... sometimes in a matter of days with this one new strategy. Some of them are retiring from their jobs because of it. Others have paid off all their debt and bought their dream homes.
You can see their stories for yourself right here.
The Bear Case For Moderna
Moderna’s share price soared to unprecedented heights this year, no doubt reflecting the special opportunity the company has with its unique and game-changing gene altering technology. Throw in a worldwide pandemic crisis that drove demand for its product, and the drug manufacturer found itself positioned as the key player in the nascent messenger RNA space. […]
Tiny Biotech Creates $2 Trillion Drug
The Wall Street Journal reports new treatment is "transforming medicine."
Bill Gates writes that it could "help humanity."
Ark Investments think it could be a "$2 trillion market."
And one small company owns the patent on it.
This unknown biotech's stock is set to surge 46,751% >>>
1 Sports Data Stock To Buy Now
Genius Sports Ltd. [NYSE: GENI] is a sports data and technology company that enables scalable, technology-led products and services to the sports, sports betting, and sports media industries. This technology enables sports leagues and federations around the globe to better capture, manage and distribute their data for enhancing their relationships with fans. Its services include: […]
Tiny Biotech Wins $75 Billion Patent
Cambridge firm proves its possible to "Find & Replace" cancer cells. The Wall Street Journal reports this small biotech is "Transforming Medicine." No wonder Goldman Sachs & Morgan Stanley have been quietly buying shares.
Get the name of this little-known stock here >>>
How Did Johnson & Johnson Start?
Johnson & Johnson (NYSE:JNJ) is one of the largest and oldest corporations in the United States, and it’s a major player in the global pharmaceutical, medical device, and consumer healthcare industries. Headquartered in New Brunswick, New Jersey, this massive enterprise includes about 250 subsidiaries across 175 countries. In 2020 alone, Johnson & Johnson generated $82.6 […]
The Common Bacteria Fighting Cancer
New breakthrough uses bacteria to "Find & Replace" cancer cells.
60 minutes calls this "the most consequential discovery in biomedicine."
A Nobel Prize winner said, "This is no longer science fiction."
Get the name of this little-known stock here >>>
Will Apple Dividend Go Up?
The Dividend Aristocrats are an elite group of companies that put a priority on payments to shareholders. Each is a member of the S&P 500, and all have increased their dividends for 25 or more consecutive years. The list includes household names like Procter & Gamble (PG), which has been increasing dividends for 65 consecutive […]
Who Are the Next Big Stock Movers?
Which stocks are hot?
Cold?
VantagePoint recognizes and calculates how markets around the world drive, impact, and influence the markets you are trading. Our patented process uses both A.I. and intermarket analysis to generate predictive learning indicators.
Get advanced notice of trend changes, and see which stocks are on the move now.
Click here for a FREE seat at our next online presentation.
5 Reasons Why Cloudflare Could Rise 200%
The S&P 500 has come close to doubling since this March 2020, going from 2,304 per share to over $,479 at its peak in mid-August of 2021. What’s more, this year-and-a-half-long hot streak shows no signs of slowing down after countless companies reported promising second quarter earnings. While plenty of companies have suffered during the […]
New Study: Americans Leaving on Average $97,347 on the Table
There's a new type of "retirement calculator" that's changing the way thousands of Americans invest. Employees at some of the richest money management firms on the planet are using this calculator, including big Wall Street banks like Bank of America, US Bank, Wells Fargo, Wachovia, Morgan Stanley, and UBS. It has been featured on Fox News, CNBC and Fox Business.
View this email online if it doesn't display correctly. This newsletter is not financial advice. Please read our Disclaimer.
To unsubscribe from Financhill, click here.
PO Box 126
Catasauqua, PA 18032
Financhill is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of Financhill are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.
The sender of this email makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity's compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.
The content on any of Financhill websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The Financhill.com educational training program and software services are provided to improve financial understanding.
The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.
Past performance is no guarantee of future performance. This product is for educational purposes only. Practical application of the products herein are at your own risk and Financhill.com, its partners, representatives and employees assume no responsibility or liability for any use or mis-use of the product. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Any trades shown are hypothetical example and do not represent actual trades. Actual results may differ. Nothing here in constitutes a recommendation respecting the particular security illustrated.
No comments:
Post a Comment